文献速递主动脉疾病

肾下腹主动脉瘤腔内修复术后II型内漏的发生率、自然病程与结局:基于ENGAGE登记数据

Incidence, natural course, and outcome of type II endoleaks in infrarenal endovascular aneurysm repair based on the ENGAGE registry data.
PubMed 文献 · J Vasc Surg · 2019-08-20

基于ENGAGE前瞻性真实世界登记数据,5年随访中孤立性II型内漏发生率为15.6%,多数无需二次干预,早期孤立性II型内漏1年内不影响健康状况;但10%的II型内漏患者后续出现迟发I型内漏,二次干预率高达67.5%。

要点

  • ENGAGE登记5年随访孤立性II型内漏发生率为15.6%,多数无需二次干预。
  • II型内漏患者动脉瘤增长和二次腔内干预发生率更高(5年15.4% vs 7.5%,P < .001)。
  • 10%的II型内漏患者出现迟发I型内漏,5年二次干预率67.5%。

核心结论

  • ENGAGE登记中孤立性II型内漏5年随访发生率为15.6%,多数无需二次干预,早期孤立性II型内漏1年内不影响健康状况。
  • 少数II型内漏患者后续出现I型内漏,导致高二次干预率和显著动脉瘤相关并发症风险。

研究设计与样本

  • 前瞻性真实世界多中心登记研究(ENGAGE),分析孤立性II型内漏患者及II型内漏后出现I型内漏的患者。
  • 比较早期II型内漏与无内漏患者的健康状况,并尝试识别II型内漏后出现I型内漏的危险因素。

主要发现

  • 5年随访共识别197例(15.6%)孤立性II型内漏,其中37.1%(n=73)在30天内检出,37.1%(n=73)在1年内检出,25.8%(n=51)在1年后检出。
  • II型内漏患者动脉瘤增长发生率更高,5年二次腔内干预率为15.4% vs 7.5%(P < .001)。
  • 孤立性II型内漏组总生存率高于无内漏组(5年77.2% vs 67.0%,P = .010)。
  • 早期II型内漏与无任何内漏患者在1年随访时健康状况评分无差异。

临床怎么用

  • 孤立性II型内漏多数可保守观察,无需常规二次干预。
  • 对II型内漏患者需警惕迟发I型内漏,应规律影像随访以及时发现并处理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The purpose of this study was to report the incidence, natural history, and outcome of type II endoleaks in the largest prospective real-world cohort to date. METHODS: Patients were extracted from the prospective Endurant Stent Graft Natural Selection Global Postmarket Registry (ENGAGE). Two groups were analyzed: first, patients with an isolated type II endoleak; and second, patients with a type II endoleak who later presented with a type I endoleak. A health status analysis between patients with an early type II endoleak and patients with no endoleak was performed. Second, an attempt was made to identify risk factors in patients with a type II endoleak who later presented with a type I endoleak. RESULTS: Through 5 years of follow-up, a total of 197 (15.6%) patients with isolated type II endoleaks were identified. Most were detected within the first 30 days (n = 73 [37.1%]) and through the first year (n = 73 [37.1%]), with the remainder being detected after 1 year of follow-up (n = 51 [25.8%]). Patients with a type II endoleak had a higher incidence of aneurysm growth and more secondary endovascular procedures (15.4% vs 7.5% at 5 years; P < .001). Overall survival was higher in the isolated type II endoleak group compared with patients with no endoleak (77.2% vs 67.0% at 5 years; P = .010). Twenty-two patients (10%) with a type II endoleak were diagnosed with a late type I endoleak (type IA, n = 10; type IB, n = 12), with a secondary intervention rate of 67.5% through 5 years. There was no difference in health status scores between patients with an early type II endoleak and patients without any type of endoleak at 1-year follow-up. CONCLUSIONS: In the ENGAGE registry, isolated type II endoleaks are present in 15.6% of patients during follow-up. The majority do not require secondary intervention, and an early isolated type II endoleak does not have an impact on health status through 1 year. However, a small group of patients with a type II endoleak will present with a type I endoleak, resulting in a high secondary intervention rate and significant risk of aneurysm-related complications.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Dijkstra ML, Zeebregts CJ, Verhagen HJM, et al. Incidence, natural course, and outcome of type II endoleaks in infrarenal endovascular aneurysm repair based on the ENGAGE registry data. J Vasc Surg. 2019. PMID: 31443976. doi:10.1016/j.jvs.2019.04.486

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。